Neomycin And Polymyxin B Sulfates And Hydrocortisone Suspension
Product Images NDC 61314-645

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Hydrocortisone (NDC 61314-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a product description of a pharmaceutical drug called "Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP". The suspension is intended for use only in the ear, and manufactured by Sandoz Inc. Each mL contains Neomycin, Polymyxin, and Hydrocortisone. The vehicle contains Thimerosal and Hydrocortisone Glycol, Polysorbate 80, Glacial Acetic Acid, and so on. The indications, dosage, precautions, etc. are provided in the package insert. The product comes in a sterile ear suspension of 10mL and is produced by Alcon. The text includes a lot of information about the constituents, but it is not available what it is exactly for.*

FDA Label Image

Hydrocortisone-chemical (Hydrocortisone Chemical)

FDA Label Image

Polymyxin-text (Polymyxin Text)

Palymyzin Bi and Palymysin B are compounds possibly used in scientific research or medical applications. The presence of DAB or y-diaminobutyric acid in one of the compounds suggests that it may have antimicrobial properties. However, without more context or information, it is difficult to ascertain the specific uses or properties of these compounds.*

FDA Label Image

Structure1

FDA Label Image

Structure2

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.